For people living with non-small cell lung cancer (NSCLC) that has spread to other parts of the body or cannot be removed by surgery, and whose tumor is KRAS G12C positive, and who have received at least one prior treatment.1



Lumakras icon
  • LUMAKRAS™ is specifically designed for tumors with the KRAS G12C mutation1
  • In tumors with this KRAS mutation, the protein remains mostly in an “on” position, and cells are continuously forced to grow2
  • LUMAKRAS™ targets the mutated KRAS protein and locks it in the “off” position. This may prevent tumor cell growth3

If your cancer is KRAS G12C positive and has been treated with a prior therapy, such as chemotherapy or immunotherapy, ask your doctor if LUMAKRAS may be able to help.1